Patent Assignment
Reel/Frame 060240/0532
Assignment of Assignor's Interest
Recorded: 2022-06-17
Pages: 5
Assignor
SCHELLING, D. CHRISTOPHER
Executed: 2022-06-10
Assignee
ACER THERAPEUTICS INC.
ONE GATEWAY CENTER, 300 WASHINGTON STREET, SUITE 351, NEWTON, MASSACHUSETTS, 02458
Covered Properties
(3)
Methods for Treating Patients with NK3 Antagonists Having Low Estrogen
Application:
63/305,207 →
Methods for Treating Patients Having Low Estrogen with NK3 Antagonists
Application:
63/306,216 →
Methods for Treating Patients Having Low Estrogen with NK3 Antagonists
Application:
63/336,943 →
Related Assignments
(3)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Interest
Mar 11, 2022
From: ACER THERAPEUTICS INC.
To: SWK FUNDING LLC
Reel/Frame 059237/0638 →
Security Interest
Jul 6, 2023
From: SWK FUNDING LLC; ACER THERAPEUTICS INC
To: NANTAHALA CAPITAL MANAGEMENT, LLC
Reel/Frame 064167/0828 →
Release of Security Interest
Apr 5, 2024
From: ZEVRA THERAPEUTICS INC. (AS SUCCESSOR IN INTEREST TO NANTAHALA CAPITAL MANAGEMENT, LLC, AS SUCCESSOR IN INTEREST TO SWK FUNDING LLC)
To: ACER THERAPEUTICS INC.
Reel/Frame 067020/0036 →